About AbbVie
AbbVie is a company based in Chicago (United States) founded in 2012. The company has 55,000 employees as of December 31, 2024. AbbVie has completed 18 acquisitions, including AMAL Therapeutics, Aliada Therapeutics and Allergan. AbbVie operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Chicago, United States
- Employees 55000 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abbvie Inc.
-
Annual Revenue
$56.33 B (USD)3.71as on Dec 31, 2024
-
Net Profit
$4.24 B (USD)-12.07as on Dec 31, 2024
-
EBITDA
$25.01 B (USD)-6.61as on Dec 31, 2024
-
Latest Funding Round
$5.9 B (USD), Debt – Conventional
Oct 03, 2018
-
Investors
Not available
-
Employee Count
55000
as on Dec 31, 2024
-
Investments & Acquisitions
AMAL Therapeutics
& 17 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of AbbVie
AbbVie is a publicly listed company on the NYSE with ticker symbol ABBV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of AbbVie
Unlock access to complete
Unlock access to complete
Leadership Team
326 people
Software Development Team
295 people
Sales and Marketing
173 people
Senior Team
76 people
Product Management Team
75 people
Human Resources and Administration
63 people
Operations Team
56 people
Data Analysis and Operations Team
47 people
Unlock access to complete
Funding Insights of AbbVie
Investments & Acquisitions by AbbVie
AbbVie has strategically engaged in corporate development activities, having acquired 18 companies. Notable acquisitions include AMAL Therapeutics, Aliada Therapeutics and Allergan.
Investment portfolio details for AbbVie
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of therapeutics for immunological and inflammatory disorders
|
Locked | Locked | 2022 | Locked | |
|
Provider of drug research & development services for multiple therapeutic areas
|
Locked | Locked | 2021 | Locked | |
|
Cell therapies are developed for oncology and other diseases.
|
Locked | Locked | 2021 | Locked |
Complete acquisition details for AbbVie
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - AbbVie
Detailed financials for AbbVie
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abbvie Comparisons
Peer comparison for AbbVie
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AbbVie
AbbVie operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
Detailed competitors of AbbVie
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abbvie
Complete news archive for AbbVie
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AbbVie
AbbVie was founded in 2012.
AbbVie is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
As of Dec 31, 2024, the latest employee count at AbbVie is 55,000.
Annual revenue of AbbVie is $56.33B as on Dec 31, 2024.
AbbVie was established in 2012 and is based in Chicago, United States, within the biopharmaceutical sector. Global operations involve the creation of treatments for autoimmune diseases and other conditions, including adalimumab marketed as Humira, alongside AndroGel, Kaletra, and Norvir. Medicines are distributed worldwide through research-driven processes. In 2022, revenues totaling 56.74 billion were reported, with net profits reaching 7.54 billion.
AbbVie's top competitors include Merck, Roivant Sciences and Lilly.
Yes, AbbVie is publicly traded on NYSE under the ticker symbol ABBV.
AbbVie has made 18 acquisitions, including AMAL Therapeutics, Aliada Therapeutics, and Allergan.
The ticker symbol of AbbVie is ABBV on NYSE.